Article Details

Morgan Stanley Increases Quest Diagnostics (NYSE:DGX) Price Target to $136.00

Retrieved on: 2021-03-12 12:48:22

Tags for this article:

Click the tags to see associated articles and topics

Morgan Stanley Increases Quest Diagnostics (NYSE:DGX) Price Target to $136.00. View article details on hiswai:

Excerpt

The brokerage currently has an "equal weight" rating on the medical research company's stock. Morgan Stanley's price objective would indicate a ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo